Navigation Links
Victhom announces promising results on the proof of concept for its unique closed-loop neuromodulation system
Date:4/16/2008

QUEBEC CITY, April 16 /PRNewswire-FirstCall/ - Victhom Human Bionics Inc. (Victhom, TSX: VHB) today disclosed initial results from the ongoing human clinical trial of its Closed-Loop neuromodulation System (CLS) used in the Neurostep(TM) for the treatment of patients suffering from foot drop secondary to a central nervous system lesion. According to the Company, the initial results of the trial have demonstrated that the Neurostep(TM) is capable of collecting sensory signals from a nerve and of stimulating the appropriate muscle groups, which represents, to the knowledge of the Company, the world's first proof of concept in a human clinical trial of a CLS product used on peripheral nerves.

The ongoing human clinical trial on the Neurostep(TM) has two major objectives. The first objective is to evaluate the sensing and stimulation mechanisms of the product. The initial results suggest that the Neurostep(TM) is capable of collecting sensory signals from a nerve located in the thigh. The interim results also demonstrate the capacity of the Neurostep(TM), based on the information collected from the nerve, to stimulate the appropriate muscle group to lift the foot in the desired direction and in synchronization with the patient's gait.

The Company expects to announce later this year results on the second major objective of the trial aimed at evaluating the efficacy of the Neurostep (TM) in providing clinically measurable benefits, such as helping patients to walk faster and over longer distances.

Mr. Nader Kameli, Chief Operating Officer of the Neurobionix division, said: "We are excited about the initial results coming out of the clinical trial, which further increase our confidence in the ability of the closed-loop technology to open the door to next generation products in the neuromodulation industry that can deliver therapy to patients in a more effective manner than the continuous or pre-programmed stimulation regimen delivered by current
'/>"/>

SOURCE VICTHOM HUMAN BIONICS INC.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Oncolytics Biotech Inc. Announces Gene Therapy Publication on Reovirus Treatment for Melanoma
2. EMD Serono Announces Planned Investment of $50 Million in Research Center in Massachusetts
3. Angiotech announces director resignation
4. BioHorizons Announces the Purchase of Implant Logic Systems
5. CV Therapeutics Announces $185 Million Transaction with TPG-Axon Capital for Half of Royalty for Lexiscan(TM) (regadenoson) Injection
6. Arpida Announces Conference Call on 17 April
7. Arpida Announces Agenda Items for Shareholders Meeting
8. BioMed Realty Trust Announces Retirement of Mark Riedy From Its Board of Directors
9. Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Patients
10. Boston Scientific Announces Japanese Approval of Heart Failure Lead
11. Vasogen Announces Implementation of Strategic Restructuring Plan

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...IENNA, Austria, November 19 AFFiRi... one product candidate at an unexpectedly early,st...planned to enter into,Phase II clinical trial earl...y follows the completion of two Phase I trials wit...its fast decision on the first interim,analysis of...
(Date:11/18/2009)...nnel need to be able to find explosive materials a...aid such searches, the National Institute of Stand...Department of Homeland Security, has developed a n...e Material (SRM) 2905, Trace Particulate Explosive...ods, the SRM will be helpful in calibrating, testi...
(Date:11/18/2009)..., Calif., Nov. 18 Sangam...ay that data from the University of Pennsylvania i...amo,s zinc finger nuclease (ZFN) based product, SB...urely disclosed on the internet. ,, Data were p...Pennsylvania School of Medicine from a single subj...
(Date:11/18/2009)...STEAD, West Sussex, U.K. and CLEVELAND, Nov. 18 /P...Biosciences business and premier provider of diagn...obiology labs, has expanded its East Grinstead, U....ility to meet increasing global demand for its Sen...identification testing. The expanded facility has ...
Breaking Biology Technology:AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3New NIST trace explosives standard slated for homeland security duty 2Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS 2TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 2TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 3TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 4
... Corporation (Nasdaq: UTHR ) announced today that... results before the open of market,on Thursday, Ju...f-hour teleconference on Thursday,July 31, 2008, a...cessible,by dialing 1-800-603-1777, with internati... of the teleconference will be available for,one w...
...announced the selection of Exiqon as the recipient...he molecular diagnostic market. This award,follows...lecular diagnostic,market., Exiqon was selected f...,of Oncotech, a market leader in the field of in v...earch team at Frost & Sullivan viewed the,acquisit...
...to standard mixes of lubricants and refrigerants c...l pill for factories, hospitals, ships, and others...sults from National Institute of Standards and Tec... formulations. , NIST experiments with varying co...major opportunity to improve the energy efficiency...
Other Biology Technology:Exiqon Receives the 2008 Frost & Sullivan Growth Strategy Leadership Award 2Exiqon Receives the 2008 Frost & Sullivan Growth Strategy Leadership Award 3Cool! Nanoparticle research points to energy savings 2
(Date:11/22/2009)...only inherited gene deletion can increase the like...ow transplantation, an international team of resea...ssue of Nature Genetics . When the gene, called U...sent in the recipient,s, transplants have a signif...n as graft-versus-host disease, in which immune ce...
(Date:11/22/2009)...ists at the Brain Research Centre, a partnership o...dicine and Vancouver Coastal Health Research Insti...hanism by which brain cells die following a stroke...e. The results of the study were recently publishe...oke, many brain cells continue to die even after b...
(Date:11/20/2009)...esearch report published in the November 2009 issu...org ), scientists show how a family of genes (1-am...es) are responsible for production of ethylene. Th...and this information lays the foundation for futur...ase resistant, able to survive and thrive in diffi...
Breaking Biology News(10 mins):Gene mismatch influences success of bone marrow transplants 2Gene mismatch influences success of bone marrow transplants 3Gene mismatch influences success of bone marrow transplants 4New understanding about mechanism for cell death after stroke leads to possible therapy 2It's a gas: New discovery may lead to heartier, high-yielding plants 2iCardiac Processes Volume of Data Equivalent to One Thousand Traditional Thorough QT Studies 13242 1iCardiac Processes Volume of Data Equivalent to One Thousand Traditional Thorough QT Studies 13242 2New Laser Treatment for Cellulite Helps Fight the Battle 53029 1New Laser Treatment for Cellulite Helps Fight the Battle 53029 2New Laser Treatment for Cellulite Helps Fight the Battle 53029 3SEOhaus Specializes in Online Niche Marketing for Medical and Dental Professionals 53026 1SEOhaus Specializes in Online Niche Marketing for Medical and Dental Professionals 53026 2
...satellites currently in orbit and the National Aer...Sciences Program, scientists have been able to obs...event infectious disease outbreaks around the worl...ialists in predicting the outbreak of some of the ...uch as Ebola, West Nile virus and Rift Valley Feve...
...o available in German . , Fall, the season of ...sappearance of the color green and the simultaneou...of ripening fruit. A team led by Bernhard Krutler ...etermined that the breakdown of chlorophyll in rip...tion products as those in brightly colored leaves....
...s from the St Vincents Campus in Sydney have devel...s, common in late stage cancer, which often speeds...cine, suggest it may soon be possible to prevent t...ve treatment and improve their chances of recovery...mmunology at St Vincents Hospital and the Universi...
Other Biology News:NASA technology helps predict and prevent future pandemic outbreaks 2Ripe fruit preferred 2Australian researchers develop treatment to treat obesity 2
...eparations are prepared from customers high-copy (... scales. Small-scale (1-100mg) as well as large-s...rding to customer specifications. Each preparatio...lycerol stocks are maintained to facilitate future...
...automated gigaseal patch clamping. The system is ...els, such as hERG and ligand-gated channels, such ...ore efficient assays and faster throughput for ion... of the QPlate electrode arrays provide confidence...
...e Clamp, as a Current Clamp or as a Conductance (D...ations. Performance in any one mode is as good as...rument is made possible by very recent advances in...P) integrated circuit chips. Until very recently, ...
... larger sample volumes, automate infusions, connec...ith telemetry systems. The AccuSampler LA meets t... and primates. The system may be programmed with ...ocated outside the animal room to minimize disrupt...
Biology Products: